LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancer: experimental drug BL-B01D1 enters human trials
Disease control Recruiting nowThis early-phase study tests a new drug called BL-B01D1 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. About 570 participants will be enrolled to also see if the drug can shri…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New drug candidate BL-M07D1 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug, BL-M07D1, in about 26 adults with advanced HER2-positive or HER2-low breast cancer or other solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and get an early look at …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New drug tracking study aims to learn how saruparib moves through the body
Knowledge-focused Recruiting nowThis early-phase study looks at how the drug saruparib is absorbed, distributed, broken down, and removed from the body in 8 people with advanced solid tumors. Participants receive a single oral dose and a single intravenous dose with a radioactive tracer to track the drug. The g…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC